BIGG

Management of Dyslipidemia for cardiovascular disease risk Reduction: synopsis of the 2020 updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline

O'Malley, Patrick G; Arnold, Michael J; Pharm, Cathy Kelley; Spacek, Lance; Buelt, Andrew; Natarajan, Sundar; Donahue, Mark P; Vagichev, Elena; Ballard-Hernandez, Jennifer; Logan, Amanda; Thomas, Lauren; Ritter, Joan; Neubauer, Brian E; Downs, John R.

In June 2020, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) released a joint update of their clinical practice guideline for managing dyslipidemia to reduce cardiovascular disease risk in adults. This synopsis describes the major recommendations. The guideline panel de...

Enfermedades Cardiovasculares/prevención & control, Enfermedades Cardiovasculares/diagnóstico, Dislipidemias/prevención & control, Dislipidemias/diagnóstico, Práctica Clínica Basada en la Evidencia, Rehabilitación Cardiaca, Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico

Texto completo

Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 U. S. Department of Veterans Affairs and U. S. Department of Defense clinical practice guideline

DESCRIPTION: In December 2014, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of dyslipidemia for cardiovascular disease risk reduction in adults. This synopsis summarizes the major recommendations. METHODS...